The Journal of Clinical Psychiatry

Page 692

More JCP Articles

Brainstorms

Substance P and the Neurokinins: Novel Peptide Neurotransmitters in Psychopharmacology

February 28, 1999

Stephen M. Stahl

Letter to the Editor

Visual Field “Shimmering” Associated With Nefazodone

February 28, 1999

William M. Greenberg

Letter to the Editor

Pharmacists Lack Knowledge of Antidepressant Discontinuation Symptoms

February 18, 1999

John Donoghue , Peter Haddad

Article

Anticonvulsant Therapy and Suicide Risk in Affective Disorders

February 1, 1999

Frederick K. Goodwin

Article

Antidepressants and Suicidal Risk

February 1, 1999

Bruno Müller-Oerlinghausen , Anne Berghöfer

Article

Do Antipsychotic Medications Decrease the Risk of Suicide in Patients With Schizophrenia?

February 1, 1999

Danica D. Palmer , Ioline D. Henter , Richard Jed Wyatt

Supplement Article

Consensus Discussion: Effects of Medical Interventions on Suicidal Behavior

February 1, 1999

Article

Depression Screening as an Intervention Against Suicide

February 1, 1999

Douglas G. Jacobs

Supplement Article

Depression Screening and Suicide Risk

February 1, 1999

Article

Effects of Lithium Treatment and Its Discontinuation on Suicidal Behavior in Bipolar Manic-Depressive Disorders

February 1, 1999

Ross J. Baldessarini , Leonardo Tondo , John Hennen

Article

Electroconvulsive Therapy and Suicide Risk

February 1, 1999

Joan Prudic , Harold A. Sackeim

Article

Expression of the Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) and MARCKS-Related Protein (MRP) in the Prefrontal Cortex and Hippocampus of Suicide Victims

February 1, 1999

Robert K. McNamara , Thomas M. Hyde , Joel E. Kleinman , et al

« 1 … 690 691 692 693 694 … 754 »

Substance P and the Neurokinins: Novel Peptide Neurotransmitters in Psychopharmacology

Visual Field “Shimmering” Associated With Nefazodone

Pharmacists Lack Knowledge of Antidepressant Discontinuation Symptoms

Anticonvulsant Therapy and Suicide Risk in Affective Disorders

Antidepressants and Suicidal Risk

Do Antipsychotic Medications Decrease the Risk of Suicide in Patients With Schizophrenia?

Consensus Discussion: Effects of Medical Interventions on Suicidal Behavior

Depression Screening as an Intervention Against Suicide

Depression Screening and Suicide Risk

Effects of Lithium Treatment and Its Discontinuation on Suicidal Behavior in Bipolar Manic-Depressive Disorders

Electroconvulsive Therapy and Suicide Risk

Expression of the Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) and MARCKS-Related Protein (MRP) in the Prefrontal Cortex and Hippocampus of Suicide Victims

ELSEWHERE:

FOLLOW US:

More JCP Articles

Substance P and the Neurokinins: Novel Peptide Neurotransmitters in Psychopharmacology

Visual Field “Shimmering” Associated With Nefazodone

Pharmacists Lack Knowledge of Antidepressant Discontinuation Symptoms

Anticonvulsant Therapy and Suicide Risk in Affective Disorders

Antidepressants and Suicidal Risk

Do Antipsychotic Medications Decrease the Risk of Suicide in Patients With Schizophrenia?

Consensus Discussion: Effects of Medical Interventions on Suicidal Behavior

Depression Screening as an Intervention Against Suicide

Depression Screening and Suicide Risk

Effects of Lithium Treatment and Its Discontinuation on Suicidal Behavior in Bipolar Manic-Depressive Disorders

Electroconvulsive Therapy and Suicide Risk

Expression of the Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) and MARCKS-Related Protein (MRP) in the Prefrontal Cortex and Hippocampus of Suicide Victims

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles